Anticancer Efficacy of Thevetia peruviana (Pers.) K. Schum. Extracts on Triple Negative Human Breast Cancer Cell Line
S. Rajhans, K. Bhadresha, D. K. Yadav, R. M. Rawal, H. A. Pandya, A. U. Mankad
European Journal of Medicinal Plants · pp. 64–69 · Published 19 Feb 2020
10.9734/ejmp/2020/v31i130206Abstract
In this 21st century cancer has become the second big reason for death next to heart attack in both developed and the developing countries. Worldwide, there are almost 2.1 million newly diagnosed breast cancer cases in 2018, accounting for 1 in 4 cancer cases among women. Triple Negative Human Breast Cancer is one of the types of human breast cancer. The plant extracts of Thevetia peruviana (Pers.) K. Schum. has been used against the Triple Negative Human Breast Cancer cell line MDA-MB-231 for the current experiment All the 5 parts (leaf, stem, flower, fruit and seed) had been selected for the experiment and the extracts of the various parts were made in hydro-alcoholic solvent i.e. methanol: Water.
Cited by 1
T.M. Abdelghany, Reham Yahya, Marwah M. Bakri · International Journal of Pharmacology · 2021
Related research
- Antioxidant, Anticancer and Antimicrobial, Effects of Rubia cordifolia Aqueous Root Extract — shares topic coverage
- Anti-tumor Effect of Calloselasma rhodostoma Venom on Human Breast Cancer Cell Line — shares topic coverage
- Herbal Remedies for Jaundice: An Exploration of Traditional Knowledge of India — shares topic coverage
- Therapeutic Uses of False Sesame (Ceratotheca sesamoides Endl.) in the Sudanian and Sudano-Sahelian Part of Burkina Faso — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.